Payden & Rygel
- SEC CIK
- 0000919219
- Latest filing
- Jul 31, 2026
ELV holding history
Elevance Health, Inc. in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELV overviewAll 13F holders of ELVFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −40,900−100.0% | Sold out | Holders |
| Q1 2023 | 40,900 | $18.8M | 1.1% | −27,000−39.8% | Reduced | Holders |
| Q4 2022 | 67,900 | $34.8M | 1.9% | +1,500+2.3% | Added | Holders |
| Q3 2022 | 66,400 | $30.2M | 1.8% | +27,200+69.4% | Added | Holders |
| Q2 2022 | 39,200 | $18.9M | 1.1% | +35,400+931.6% | Added | Holders |
| Q1 2022 | 3,800 | $1.87M | 0.1% | +1,900+100.0% | Added | Holders |
| Q4 2021 | 1,900 | $881.0K | <0.1% | −63,200−97.1% | Reduced | Holders |
| Q3 2021 | 65,100 | $24.3M | 1.3% | −200−0.3% | Reduced | Holders |
| Q2 2021 | 65,300 | $24.9M | 1.2% | +100+0.2% | Added | Holders |
| Q1 2021 | 65,200 | $23.4M | 1.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.